Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,007 | 44,200 | 2,025 | 5,830 | 7,226 |
| Marketable Securities | 28,976 | N/A | N/A | N/A | N/A |
| Receivables | N/A | 200 | N/A | N/A | N/A |
| TOTAL | $55,620 | $44,693 | $2,324 | $6,053 | $7,503 |
| Non-Current Assets | |||||
| PPE Net | 230 | 383 | N/A | N/A | N/A |
| Investments And Advances | 4,645 | 40,205 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 2,705 | 400 | 0 |
| TOTAL | $4,875 | $40,588 | $2,705 | $400 | $N/A |
| Total Assets | $60,495 | $85,281 | $5,030 | $6,453 | $7,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,474 | 5,014 | 5,501 | 1,582 | 634 |
| TOTAL | $4,474 | $5,014 | $5,501 | $1,582 | $634 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 2,037 | 1,665 | 1,017 |
| TOTAL | $608 | $643 | $2,037 | $1,665 | $1,017 |
| Total Liabilities | $5,082 | $5,657 | $7,538 | $3,248 | $1,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,820 | 13,199 | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -60,196 | -31,366 | -7,169 | -895 | 1,860 |
| Other shareholders' equity | 3 | -44 | 0 | 0 | 0 |
| TOTAL | $55,413 | $79,624 | $-2,508 | $3,205 | $5,852 |
| Total Liabilities And Equity | $60,495 | $85,281 | $5,030 | $6,453 | $7,503 |